These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18339885)

  • 1. Dietary genistein inhibits metastasis of human prostate cancer in mice.
    Lakshman M; Xu L; Ananthanarayanan V; Cooper J; Takimoto CH; Helenowski I; Pelling JC; Bergan RC
    Cancer Res; 2008 Mar; 68(6):2024-32. PubMed ID: 18339885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway.
    Xu L; Bergan RC
    Mol Pharmacol; 2006 Sep; 70(3):869-77. PubMed ID: 16772519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells.
    Huang X; Chen S; Xu L; Liu Y; Deb DK; Platanias LC; Bergan RC
    Cancer Res; 2005 Apr; 65(8):3470-8. PubMed ID: 15833883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model.
    Vantyghem SA; Wilson SM; Postenka CO; Al-Katib W; Tuck AB; Chambers AF
    Cancer Res; 2005 Apr; 65(8):3396-403. PubMed ID: 15833874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis.
    Rocchi P; Beraldi E; Ettinger S; Fazli L; Vessella RL; Nelson C; Gleave M
    Cancer Res; 2005 Dec; 65(23):11083-93. PubMed ID: 16322258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2.
    Chang HL; Wu YC; Su JH; Yeh YT; Yuan SS
    J Pharmacol Exp Ther; 2008 Jun; 325(3):841-9. PubMed ID: 18337475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celastrol acts as a potent antimetastatic agent targeting beta1 integrin and inhibiting cell-extracellular matrix adhesion, in part via the p38 mitogen-activated protein kinase pathway.
    Zhu H; Liu XW; Cai TY; Cao J; Tu CX; Lu W; He QJ; Yang B
    J Pharmacol Exp Ther; 2010 Aug; 334(2):489-99. PubMed ID: 20472666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity.
    Zoubeidi A; Zardan A; Beraldi E; Fazli L; Sowery R; Rennie P; Nelson C; Gleave M
    Cancer Res; 2007 Nov; 67(21):10455-65. PubMed ID: 17974989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.
    Schwock J; Dhani N; Cao MP; Zheng J; Clarkson R; Radulovich N; Navab R; Horn LC; Hedley DW
    Cancer Res; 2009 Jun; 69(11):4750-9. PubMed ID: 19458065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranilast inhibits the growth and metastasis of mammary carcinoma.
    Chakrabarti R; Subramaniam V; Abdalla S; Jothy S; Prud'homme GJ
    Anticancer Drugs; 2009 Jun; 20(5):334-45. PubMed ID: 19322072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer.
    Xu L; Chen S; Bergan RC
    Oncogene; 2006 May; 25(21):2987-98. PubMed ID: 16407830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genistein enhances TRAIL-induced apoptosis through inhibition of p38 MAPK signaling in human hepatocellular carcinoma Hep3B cells.
    Jin CY; Park C; Kim GY; Lee SJ; Kim WJ; Choi YH
    Chem Biol Interact; 2009 Jul; 180(2):143-50. PubMed ID: 19497411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthotopically implanted SCID mouse model of human lung cancer suitable for investigating metastatic potential and anticancer drug effects.
    Kondo K; Fujino H; Miyoshi T; Ishikura H; Sakiyama S; Monden Y
    Oncol Rep; 2004 Nov; 12(5):991-9. PubMed ID: 15492783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noscapine inhibits human prostate cancer progression and metastasis in a mouse model.
    Barken I; Geller J; Rogosnitzky M
    Anticancer Res; 2008; 28(6A):3701-4. PubMed ID: 19189652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Garlic-derived S-allylmercaptocysteine is a novel in vivo antimetastatic agent for androgen-independent prostate cancer.
    Howard EW; Ling MT; Chua CW; Cheung HW; Wang X; Wong YC
    Clin Cancer Res; 2007 Mar; 13(6):1847-56. PubMed ID: 17363541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumor model.
    Wang Y; Raffoul JJ; Che M; Doerge DR; Joiner MC; Kucuk O; Sarkar FH; Hillman GG
    Radiat Res; 2006 Jul; 166(1 Pt 1):73-80. PubMed ID: 16808622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide.
    Papo N; Seger D; Makovitzki A; Kalchenko V; Eshhar Z; Degani H; Shai Y
    Cancer Res; 2006 May; 66(10):5371-8. PubMed ID: 16707464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory role of focal adhesion kinase on anoikis in the lung cancer cell A549.
    Liu G; Meng X; Jin Y; Bai J; Zhao Y; Cui X; Chen F; Fu S
    Cell Biol Int; 2008 Jun; 32(6):663-70. PubMed ID: 18343694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer.
    Miwa S; Mizokami A; Keller ET; Taichman R; Zhang J; Namiki M
    Cancer Res; 2005 Oct; 65(19):8818-25. PubMed ID: 16204052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.